Nariman Mehta

Nariman Bomanshaw Mehta
File:Nariman Mehta.jpg Nariman Bomanshaw Mehta
Born	(1920-04-20)April 20, 1920 Bombay, India
Died	Burlington, NC
Citizenship	United States
Nationality	United States
Fields	Organic chemistry
Institutions	Seagram, GlaxoSmithKline
Alma mater	St. Xavier's College, Mumbai, University of Kansas
Known for	Synthesis of antidepressant drug Bupropion (marketed as Wellbutrin)
Spouse	Barbara DeShane
Children	2 daughters, 1 son

Nariman Bomanshaw Mehta (April 8, 1920 – August 22, 2014) was an Indian-born American organic chemist and pharmacologist who designed, synthesized, and patented the organic compound Bupropion, marketed under the name Wellbutrin as an antidepressant and smoking cessation aid.

Early life and education

Mehta was born in Bombay, India. He attended St. Xavier's College in Bombay, from where he received Bachelor of Science degrees in chemistry and physics and Bachelor of Arts degrees in English and economics, and a Master of Science degree. In 1939, he and a fellow student K. D. Irani wrote and published the book “Textbook of Theoretical and Practical Physics”.

Mehta won a Tata Scholarship and received a grant from Wendell Willkie. In 1947 Mehta went to the United States, where he earned a PhD in chemistry from The University of Kansas.

He had two daughters and a son.

Career

Seagram invited Mehta to the United States as a trainee in their research lab where he learnt about fermentation and distillation. During his time at Seagram, Mehta studied the antibiotic Penicillin. While teaching chemistry at Central State University, Wilberforce, Ohio, Mehta joined the pharmaceutical company Burroughs Wellcome, Inc., now GlaxoSmithKline, where he worked on potential neuropsychopharmacological drugs and designed, synthesized, and patented (in 1969) the compound Bupropion (BW 323U66) that was approved for use as an antidepressant in 1985 and sold under the trade name Wellbutrin. Another application of the drug was as a smoking cessation aid.